Flexible Dosing to Help Prevent PCV2 Viraemia

by 5m Editor
16 May 2012, at 7:40am

US - Now offering a high standard in protocol flexibility, FosteraTM PCV is the only PCV vaccine that can be incorporated into vaccination programs using either two doses or one to help prevent Porcine Circovirus Type 2 (PCV2) viraemia and help control lymphoid depletion.

"This flexible dosing claim is another example of our commitment to veterinarian and producer customers and our desire to provide them with options for handling protocols that vary from farm to farm," says Darrell Neuberger, DVM, pork technical services veterinarian for Pfizer Animal Health.

Any amount of PCV2 viremia may negatively impact production, so the goal of vaccination is to create an environment with the least amount of virus present. A study demonstrated that vaccination of pigs with two doses of Fostera PCV compared to non-vaccinated pigs helped prevent PCV2 viremia and helped provide protection against PCV2 infection in lymphatic tissues1:

  • Reduced viremia by up to 8,000 times post-challenge, resulting in a total of 96.8 per cent viremia-free days while in study
  • All lymphatic tissues in vaccinated pigs were negative for PCV2 infection

"Whether you decide to administer two doses or one of Fostera PCV, both options effectively offer a high standard of consistent performance to help protect pigs against this performance-robbing disease," says Dr Neuberger.

Fostera PCV, which will have a new look featuring a large PCV mark in the upcoming months, can be administered in two ways:

  • Two 1-mL doses 3 weeks apart starting at 3 weeks of age or older
  • One 2-mL dose at 3 weeks of age or older
Fostera PCV is available from your veterinarian or animal health supplier. For more information, talk to your veterinarian, Pfizer Animal Health representative, visit or call toll-free 855-424-7349.

Pfizer Animal Health, a business of Pfizer Inc., is a world leader in discovering and developing innovative animal vaccines, medicines, diagnostic products and genetic tests, investing an estimated $300 million annually in animal health product research and development. For more information about how Pfizer Animal Health works to ensure a safe, sustainable global food supply from healthy swine and other livestock, visit

1. Data on file, Study Report No. 3420R-60-10-938, Pfizer Inc.

Visit our PMWS page by clicking here.